Halocur |
Veterinary |
halofuginone |
halofuginone |
EMEA/V/C/000040 |
Intervet International BV |
1999/10/29
|
Authorised |
Doxirobe |
Veterinary |
Doxycycline |
doxycycline |
EMEA/V/C/000044 |
Pfizer Limited |
1999/09/16
|
Withdrawn |
NovoRapid |
Human |
insulin aspart |
insulin aspart |
EMEA/H/C/000258 |
Novo Nordisk A/S |
1999/09/07
|
Authorised |
Arava |
Human |
leflunomide |
leflunomide |
EMEA/H/C/000235 |
Sanofi-aventis Deutschland GmbH |
1999/09/02
|
Authorised |
Ferriprox |
Human |
deferiprone |
Deferiprone |
EMEA/H/C/000236 |
Chiesi Farmaceutici S.p.A. |
1999/08/25
|
Authorised |
Remicade |
Human |
infliximab |
infliximab |
EMEA/H/C/000240 |
Janssen Biologics B.V. |
1999/08/13
|
Authorised |
Synagis |
Human |
palivizumab |
palivizumab |
EMEA/H/C/000257 |
AstraZeneca AB |
1999/08/13
|
Authorised |
Vitravene |
Human |
fomivirsen |
fomivirsen |
EMEA/H/C/000244 |
Novartis Ophthalmics Europe Ltd. |
1999/07/29
|
Withdrawn |
Zeffix |
Human |
lamivudine |
lamivudine |
EMEA/H/C/000242 |
GlaxoSmithKline (Ireland) Limited |
1999/07/29
|
Authorised |
Paxene |
Human |
paclitaxel |
paclitaxel |
EMEA/H/C/000216 |
Norton Healthcare Ltd. |
1999/07/19
|
Withdrawn |
Ziagen |
Human |
abacavir |
abacavir |
EMEA/H/C/000252 |
ViiV Healthcare B.V. |
1999/07/08
|
Authorised |
Integrilin |
Human |
eptifibatide |
eptifibatide |
EMEA/H/C/000230 |
GlaxoSmithKline (Ireland) Limited |
1999/07/01
|
Authorised |
Stocrin |
Human |
efavirenz |
efavirenz |
EMEA/H/C/000250 |
Merck Sharp & Dohme B.V. |
1999/05/28
|
Authorised |
Sustiva |
Human |
efavirenz |
efavirenz |
EMEA/H/C/000249 |
Bristol-Myers Squibb Pharma EEIG |
1999/05/28
|
Withdrawn |
Rotashield |
Human |
rotavirus vaccine |
rotavirus serotype 1 reassortant, rotavirus serotype 2 reassortant, rotavirus serotype 3 rhesus, rotavirus serotype 4 reassortant |
EMEA/H/C/000192 |
Wyeth Lederle Vaccines S.A. |
1999/05/07
|
Withdrawn |
Procomvax |
Human |
haemophilus B conjugate (meningococcal protein conjugate) and hepatitis B (recombinant) vaccine |
polyribosylribitol phosphate from Haemophilus influenzae type b as PRP-OMPC;outer membrane protein complex of Neisseria meningitidis (outer membrane protein complex of the B11 strain of Neisseria meningitidis subgroup B);adsorbed hepatitis B surface antigen produced in recombinant yeast cells (Saccharomyces cerevisiae) |
EMEA/H/C/000231 |
Sanofi Pasteur MSD, SNC |
1999/05/07
|
Expired |
Cotronak |
Human |
ribavirin |
Ribavirin |
EMEA/H/C/000247 |
Schering-Plough Europe |
1999/05/07
|
Withdrawn |
Rebetol |
Human |
ribavirin |
Ribavirin |
EMEA/H/C/000246 |
Merck Sharp and Dohme B.V |
1999/05/06
|
Withdrawn |
ReFacto AF |
Human |
moroctocog alfa |
moroctocog alfa |
EMEA/H/C/000232 |
Pfizer Europe MA EEIG |
1999/04/13
|
Authorised |
Cetrotide |
Human |
cetrorelix |
cetrorelix (as acetate) |
EMEA/H/C/000233 |
Merck Europe B.V. |
1999/04/12
|
Authorised |